跳至主要内容
临床试验/JPRN-UMIN000009150
JPRN-UMIN000009150招募中2 期

Feasibility study of agjuvant chemotherapy with docetaxel, cisplatin and fluorouracil for esophageal cancer - Feasibility study of agjuvant chemotherapy for esophageal cancer

Shimane University Hospital0 个研究点目标入组 50 人开始时间: 2012年10月19日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Past history of drug allergy 2)Past history of drug allergy of docetaxel, cisplati and fluorouracil 3)Patient with clinically obvious infecton 4)Women who are pregnant, breastfeeding, or potentially (hoping to become) pregnant 5)Disease that is serious or requires hospitalization, or history of such disease within past year 6)Difficulty to join the trial due to psychosis or psychotic symptoms or central nervous system damage 7)Massive pleural effusion, ascites and pericardial effusion 8)Gastrointestinal hemorrhage 9)Chronic diarrhea (watery stool or 4 times or more/day) 10)Active hepatitis type HBs positive 11)More than one cancer at the same time or more than one cancer at different times separated by a 5-year disease-free interval. However, multiple active cancers do not include carcinoma in situ or skin cancer which is determined to have been cured as a result of treatment. 12)Otherwise determined by investigators or site principal investigators to be unsuitable for participation in study

研究者

相似试验